(Q48660059)

14 February 2018

title

Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease. (English)

1 reference

14 February 2018

1 reference

1 reference

Dao-Ying Geng

1

1 reference

14 February 2018

Yu-Xin Li

series ordinal

2

1 reference

14 February 2018

Chi-Shing Zee

series ordinal

3

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 February 2006

1 reference

14 February 2018

published in

Neurosurgery

1 reference

14 February 2018

volume

58

1 reference

14 February 2018

issue

2

1 reference

14 February 2018

page(s)

256-62; discussion 256-62

1 reference

14 February 2018

MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

PET and SPECT functional imaging in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Magnetic resonance imaging of the midbrain in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Correspondence of microelectrode mapping with magnetic resonance imaging for subthalamic nucleus procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

The subthalamic nucleus in the context of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Correlating rates of cerebral atrophy in Parkinson's disease with measures of cognitive decline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Reliability and exactness of MRI-based volumetry: a phantom study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

21 January 2018

1 reference

https://api.crossref.org/works/10.1227%2F01.NEU.0000194845.19462.7B

10.1227/01.NEU.0000194845.19462.7B

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018